Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 2Phase 3 1

Status

Completed 21Recruiting 6Unknown 5Withdrawn 4Terminated 3Not yet recruiting 1No longer available 1

Sponsor Class

OTHER 6NETWORK 2

Study Type

Interventional 6

Sponsor

Cancer Type

Sarcoma 6

Conditions

Sarcoma 4Leiomyosarcoma 2Liposarcoma, Myxoid 1Liposarcoma 1Leiomyosarcoma Uterus 1

Interventions

Specimen Handling 336Magnetic Resonance Spectroscopy 333Radiotherapy 315Cyclophosphamide 295pembrolizumab 282Cisplatin 266Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 206Bevacizumab 187Gemcitabine 177venetoclax 172Radiosurgery 169Capecitabine 165Oxaliplatin 163fludarabine 160Nivolumab 156Paclitaxel 155Standard of Care 137Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 127Fluorouracil 125Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104atezolizumab 101Azacitidine 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × OTHER × Trabectedin × Clear all
NCT05597917 2025-04-04

TRABTRAP

Universität Münster

Phase 3 Recruiting
126 enrolled
Sarcoma

Sarcoma

NCT06524583 2025-03-30

L-UteCIN

UNICANCER

Phase 2 Recruiting
198 enrolled
Sarcoma

Leiomyosarcoma Uterus

NCT03138161 2025-02-24

SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma

Sarcoma Oncology Research Center, LLC

Phase 1/2 Recruiting
250 enrolled
Sarcoma

Sarcoma

NCT03886311 2025-02-24

TNT

Sarcoma Oncology Research Center, LLC

Phase 2 Recruiting
200 enrolled
Sarcoma

Sarcoma

NCT04535271 2025-02-24

TAGGED

Sarcoma Oncology Research Center, LLC

Phase 2 Recruiting
80 enrolled
Sarcoma

Leiomyosarcoma

NCT02275286 2023-05-31

TRASTS

Grupo Espanol de Investigacion en Sarcomas

Phase 1/2 Recruiting
199 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡